Archive for 'Biopharmacy'

Personalised arthritis medicine saves lots of money

Personalised arthritis medicine saves lots of money

Detecting arthritis early on is one of the key challenges facing rheumatology. However, some patients present with undifferentiated arthritis, meaning that it is not possible to establish a diagnosis from the initial assessment. By analyzing our [...]

Biomanufacturing: Walloon player Novasep offers now all the CDMO services!

Biomanufacturing: Walloon player Novasep offers now all the CDMO services!

In 2016 and beyond, biomanufacturing will be high among the BioWin pole priorities. A sector in which Wallonia has no shortage of qualified players and resources to ensure it is well placed to meet future challenges. [...]

Synolyne Pharma gets new patents granted in Europe and in the US

Synolyne Pharma gets new patents granted in Europe and in the US

Synolyne Pharma, a biotech spin-off company of the University of Liège and spin-out of Kitozyme SA (Belgium), has recently been granted two new patents in both Europe and the United States in relation to its chitosan-based [...]

Delphi Genetics signs international research partnership in the US

Delphi Genetics signs international research partnership in the US

Delphi Genetics S.A., a Walloon SME located in Gosselies (Belgium) partners with US company Avaxia (Lexington, Massachusetts) to develop an improved biomolecules manufacturing and immunization process for Avaxia’s lead product candidate which is in clinical development [...]

ImmunXperts: launch of a unique fully integrated Immunogenicity service provider for biotherapeutics.

ImmunXperts: launch of a unique fully integrated Immunogenicity service provider for biotherapeutics.

ImmunXperts s.a. a start-up located in Gosselies (Belgium) and specializing in the development of proprietary and innovative methods to assess the immunogenicity of novel biotherapeutics and biosimilars has raised USD 1 million in equity and bank [...]

Euroscreen signs a collaboration and licensing agreement with Merck & Co. Inc.

Euroscreen signs a collaboration and licensing agreement with Merck & Co. Inc.

Euroscreen, a Belgian drug discovery and development company providing first-in-class small molecule drug candidates for therapeutics areas such as hormonal disorders, inflammation and neurodegenerative diseases, announced an exclusive world-wide research collaboration and licensing agreement with Merck [...]

Pluriomics raises €4M and settles its production facility in Wallonia!

Pluriomics raises €4M and settles its production facility in Wallonia!

Pluriomics, an emerging biotech company located in Leiden (The Netherlands) and specializing in the delivery of innovative cardiomyocyte models, has raised €4 million in a Series A round to strengthen its R&D and commercial team in [...]

Belgo-American partnership between Promethera Biosciences and EMD Millipore to develop pre-clinical liver pharmaco-toxicological testing assay

Belgo-American partnership between Promethera Biosciences and EMD Millipore to develop pre-clinical liver pharmaco-toxicological testing assay

  The recent Belgo-American partnership between Promethera® Biosciences (Mont-Saint-Guibert, Belgium), and EMD Millipore (Billerica, MA USA) to develop an improved ready-to-use microfluidic perfusion liver assay, is BioWin’s latest ‘Success Story’. The initiative behind this strategic project [...]

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

As part of an expert pan-European consortium* BONE THERAPEUTICS has been awarded a share of the highly competitive Marie Curie grant1 in the amount of €3.8 million. The grant will fund a four-year project entitled BIO-INSPIRE [...]

Cardio3 BioSciences raises € 4.0 million from the Walloon Region (non-dilutive funding)

Cardio3 BioSciences raises € 4.0 million from the Walloon Region (non-dilutive funding)

Cardio3 BioSciences SA has announced that it has received €4.0 million of non-dilutive funding from the Walloon Region through the conclusion of a new recoverable cash advance (RCA) granted for an amount of €2.5 million and [...]